Black and white close up of woman's face

Solving America’s largest
drug problem

$552 billion is wasted annually when patients are prescribed drugs they don’t respond to.

We use a patient’s individual molecular data to ensure optimal therapy is prescribed from day one, improving lives and saving money.

Group 2

One test for
providers and payers.

A first-of-its kind blood based molecular signature test identifies a patient’s unique disease biology to determine which drug actually targets the disease, allowing providers and payers to make the right therapy decision to reach treatment goals.

Scipher molecular signature test
transparent purple network
Hand with pill

Using data from molecular signature tests to develop more effective drugs for

Clinico-genomic data collected from our tested patients and analyzed by our AI platform reveals novel insights into autoimmune diseases, such as novel drug targets specific to biologically similar patient populations.

We partner across healthcare

  • white logo for united health group
  • white logo of galapagos
  • white font for johnson and johnson
  • white logo for optum
  • white logo for Ambry Genetics